
LimmaTech Awarded FDA Fast Track Designation for Vaccine Candidate Against Staphylococcus aureus
Published on December 20, 2024
is backed by specialist healthcare investors, including Adjuvant Capital, AXA IM Alts, Novo Holdings REPAIR Impact Fund, and Tenmile. For
Other news
